Stemina Launches Cardiotoxicity Assay, Presents Sponsored Session, Poster at SOT’s Annual Meeting & ToxExpo 2018
The Stemina team will attend the Society of Toxicology’s Annual Meeting and ToxExpo in San Antonio, Texas from March 11-15, 2018. We are excited to share information about our new cardiotoxicity assay, Cardio quickPredictTM, now commercially-available for the first time.
In addition to participating in SOT as an exhibitor (booth 408), Stemina’s work will appear in four sessions:
Monday, 3/12 | 10:45 am – 12:15 pm (author-attended) | Poster session
Development of an In Vitro Assay to Predict Cardiotoxicity Potential Using Targeted Metabolomics and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Jessica Palmer, Associate Director of Toxicology, presents | Poster #P179
Tuesday, 3/13, 1:30 PM | Exhibitor-Hosted Session
Cardio quickPredictTM: A New Way to Evaluate the Cardiotoxicity Potential of Compounds
Jessica Palmer presents | Room 217A
These two presentations are part of platform session on Alternative Models for Assessing Developmental Toxicity. Though we aren’t presenting these sessions, Stemina’s assay was used for the research discussed.
- Valproate Analogue Developmental Toxicity Potency in a Human Pluripotent Stem Cell-Based Assay Is Concordant with In Vivo Potency
Nicole Kleinstreuer (NICEATM) presents | 2:50 PM | CC Room 301
- Profiling the Toxcast Library with a Pluripotent Human Embryonic Stem Cell Assay
Thomas Knudsen (EPA) presents | 3:10 PM | CC Room 301
CEO Elizabeth Donley will also attend SOT 2018. For more information, please consult the program [PDF] and the meeting’s website.